
Steven Rose obituary: Vituperative neuroscientist
On the flip side of this was a scrappy man who was quick to eviscerate fellow neuroscientists, ideas or institutions that he deemed to be leading the profession in the wrong direction. 'Combat is forced upon me,' he insisted. 'I don't go looking for combats. But they find me. When what I regard as bad or mistaken ideas are non-trivial, they need combating.'
Rose was quick to label his intellectual opponents 'fantasists', and even his penultimate book Genes, Cells and Brains in 2012 was an 'angry' tome that boasted 'abundant targets' and a 'lethally impressive hit ratio', as one reviewer observed.
An academic 'with a strongly philosophical and political cast of mind', Rose took a stance against the idea that human behaviour was determined by genes. He was adamant that 'we are free to make our own futures, though in circumstances not of our own choosing'.
This view placed him in opposition to those thinkers who argued that human nature was largely honed by evolutionary forces, and Rose took no qualms with ferociously critiquing their views. Chief among his targets were the 'reductionist' entomologist Edward O Wilson, the evolutionary theorist Richard Dawkins and the 'romanticised Stone Age nonsense' of the cognitive neuroscientist Steven Pinker.
He also directed his wrath at the enthusiasm for IQ testing in education and employment in the 1970s. Rose believed the question of what constituted 'intelligence' was problematic — arguing the word had much broader and diverse meanings than what could be encompassed in such tests — and he was adamant that intelligence was heavily reliant on a person's environment.
He was also a vocal critic of the 'pseudo-science' behind claims by thinkers such as the DNA pioneer James Watson that IQ tests showed inherent differences in intelligence between men and women, or people of different races. 'Intelligence is always intelligence-in-context,' Rose said, adding for good measure: 'Many would argue that someone who can make remarks like Watson's is singularly devoid of social intelligence, for instance.'
Although he was quick to dismiss viewpoints he deemed inaccurate, Rose was refreshingly honest about the limits of his own work. He refused to dumb down the most complex aspects of neuroscience into sweeping simplifications, and one of the most common phrases in his book The 21st-Century Brain: Explaining, Mending and Manipulating the Mind (2005) was: 'We just don't know.'
Steven Peter Russell Rose was born into an Orthodox Jewish community in north London in 1938. His father Lionel Rose (formerly Rosenberg) was a chemistry teacher who became an intelligence officer during the Second World War. He later worked as an organiser for the Association of Jewish Ex-Servicemen and Women before founding an advertising agency. His mother Ruth (née Waxman) gave up her career to look after her children but later became co-director of her husband's agency and ran it single-handedly after he died in 1959.
Rose's dual interest in socialism and science could be traced back to the events of his childhood. He described how one of his earliest memories was a violent demonstration by the Blackshirts while his father was speaking against the fascists, and said that after being given a chemistry set for his eighth birthday he set up a chemistry lab in his garden.
After attending Haberdashers' Aske's boys' school in Hertfordshire on a scholarship, he won another one to study at King's College, Cambridge, where he graduated with a double first in biochemistry in 1959. Evidently talented, but young and ambitious, Rose decided he did not want to continue in a field where there was less scope to make science-altering discoveries. 'I thought, 'The genetic code has been solved; protein synthesis has been done. What's the big next thing to understand? The brain. So where can I go to understand the brain?'' he recalled.
The sentiment went down as well as you might expect with his department, and he was 'exiled' to complete a PhD at the Institute of Psychiatry in London in 1961. It turned out to be felicitous, because he met the LSE sociology student Hilary Chantler while in London at a New Left Review meeting. The couple married shortly afterwards and were together for more than 60 years until Rose's death.
Even from this relatively young age, the young neuroscientist was interested in engaging the broader public in the knotty science of the mind. He wrote his first book explaining the basics of biochemistry to the general reader while still in his twenties. It was picked up by Penguin and published as the hugely successful paperback The Chemistry of Life in 1966.
The following year Rose became one of the founding members of a London-based discussion group that held informal monthly meetings in the upstairs room of the Black Horse pub in Rathbone Place, London. It was the precursor of the Brain Research Association, which was later renamed the British Neuroscience Association and continues to this day.
After periods of postdoctoral research at Oxford, Rome and with the Medical Research Council in London, Rose became a professor of biology at the newly formed Open University in 1968. Aged only 30, he became one of the UK's youngest professors. While at the university he established its brain and behaviour research group and remained as a professor there until 1999, though he continued to conduct research at the university for more than a decade afterwards.
Rose also took up visiting appointments in the United States, China and Australia and continued to write prolifically alongside his teaching. He penned an enormous number of papers on learning and memory and wrote several highly successful books, including The Making of Memory: From Molecules to Mind (1992), which received the Royal Society science book prize.
He wrote several of these publications with his wife Hilary, who was appointed professor of social policy at the University of Bradford in 1975. She survives him with their two sons, the farmer Simon, from Hilary's first marriage, and the criminal defence lawyer Ben. Together, the couple wrote Alas, Poor Darwin: Arguments against Evolutionary Psychology (2000), Genes, Cells and Brains: Bioscience's Promethean Promises (2012) and Can Neuroscience Change Our Minds? (2016).
They shared a keen interest in the social and legal aspects of science, and advocated for greater public engagement with ethics. They decried the shift towards an entrepreneurial focus — 'wealth creation is now unabashedly formalised as the chief objective of science and technology policy' — and were among the founders of the British Society for Social Responsibility in Science in 1969. Rose also appeared as a panel member on BBC Radio 4's Moral Maze for several years, and was awarded the Biochemical Society medal for excellence in public communication of science in 2002.
While researching cures for Alzheimer's disease Rose's work brought him into opposition with animal rights campaigners. He established an ethics committee with lay members before government legislation demanded it, reasoning: 'Such discussions are important, as each side learns to respect and attempt to accommodate the views of the other.'
His efforts did not stop the hate mail, however. 'When I informed an officer of one of the major 'anti-vivisection' organisations that our local animal rights movement included active members of a neo-Nazi group, her response was to ask me if I didn't feel like Josef Mengele, the notorious concentration camp butcher. An odd question to address to a Jew,' he added.
Rose's laboratory was a lively international hub of scientists. He had visiting researchers from countries including Argentina, France, Spain, Italy and Poland and he took a keen interest in global affairs. In 2002 Rose and his wife initiated a boycott of Israeli institutions in protest at strikes on Palestinians, backed by figures including Archbishop Desmond Tutu. The couple argued: 'The choice today for civil society — and academics and researchers are a part of civil society — is to remain silent and do nothing or to try to bring pressure to bear.'
Rose was recognised internationally for his work with the Sechenov and Anokhin medals (Russia) and the Ariens Kappers medal (the Netherlands). But one of the most promising elements of his research was his progress towards finding a novel treatment for Alzheimer's disease, for which he won the Lilly award for best innovation in mental health in 2003.
In the latter half of his career, Rose started to look towards the future of neuroscience. In 2009 he was invited to deliver a centenary lecture at Bristol University and he assembled a talk entitled: The Future of the Brain: The Promise and Perils of Tomorrow's Neuroscience. In it, he warned of the ways in which his colleagues were overreaching with their offers to 'explain, mend and manipulate the mind'.
He was wary of the role of the state and big pharmaceutical companies in research and showed particular concern about the disputed borderlines between being undesirable and being ill. Rose called on his audience to question intolerant attitudes towards age-associated memory impairment, ADHD, compliance disorder, oppositional defiant disorder, disruptive behaviour and conduct disorder. 'All of which I suspect I could have been prosecuted for or psychiatrically diagnosed with over the course of my career,' he said. 'If I hadn't been, I'd have been rather sorry that I'd failed.'
Steven Rose, neuroscientist and author, was born on July 4, 1938. He died of undisclosed causes on July 9, 2025, aged 87
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medical News Today
2 hours ago
- Medical News Today
Alzheimer's is linked to low brain lithium levels, study shows
Lithium is a mineral that can be found in nature, with small amounts also found in the human body. Past research has also shown that lithium seems to have a neuroprotective effect on the brain. A new study shows that lithium occurs naturally in the brain and plays a major role in normal brain also discovered that a loss of lithium in the brain may be an early warning sign for Alzheimer's disease because it binds to beta-amyloid is a mineral that can be found in nature. Very small amounts of lithium can also be found in the body by ingesting certain foods or drinking water with a high mineral content. Because lithium is a mood stabilizer, it is sometimes used as a medication to treat mental health conditions like mania, bipolar disorder, and depression. Past research has also shown that lithium seems to have a protective effect on the brain, potentially helping to defend against mild cognitive impairment, Parkinson's disease, Alzheimer's disease, and other types of dementia. Now, a new study published in the journal Nature provides additional evidence of lithium's potential neuroprotective study has shown, for the first time, that lithium occurs naturally in the brain and plays a major role in normal brain also discovered that a loss of lithium in the brain may be an early warning sign for Alzheimer's disease because it binds to amyloid-beta plaques, currently considered one of the hallmarks of the low lithium levels found in brain samples of Alzheimer's diseaseFor this study, researchers used a combination of testing postmortem brain tissue and a mouse model of Alzheimer's disease. Using brain tissue samples from deceased participants with a mix of healthy cognition, mild cognitive impairment, and advanced Alzheimer's disease, scientists discovered that of the 27 different trace metals in the brain, lithium was the only one that had significantly different levels across the groups. Researchers found that changes to lithium amounts in the brain started at the earliest stages of memory loss, and levels of the mineral were very low in samples from participants with mild cognitive impairment or Alzheimer's disease. Replenished lithium levels reverse brain damage in mouse modelNext, the research team used a mouse model to further confirm their hypothesis. When healthy mice were fed a lithium-reduced diet, scientists found they aged more rapidly, and experienced brain inflammation and cognitive a mouse model of Alzheimer's disease, scientists observed that lower lithium levels sped up the formation of amyloid-beta plaques and activated inflammatory cells called microglia in the brain. However, when mice were provided with a lithium compound called lithium orotate, Alzheimer's disease-related damage to the brain was reversed and memory function was restored. 'The idea that lithium deficiency could be a cause of Alzheimer's disease is new and suggests a different therapeutic approach,' Bruce Yankner, MD, PhD, professor of genetics and neurology in the Blavatnik Institute at Harvard Medical School and senior author of this study, said in a press release.'You have to be careful about extrapolating from mouse models, and you never know until you try it in a controlled human clinical trial,' Yankner cautioned, though he emphasized that 'so far the results are very encouraging.''My hope is that lithium will do something more fundamental than anti-amyloid or anti-tau therapies, not just lessening but reversing cognitive decline and improving patients' lives,' the study author lithium make the brain more resilient?Manisha Parulekar, MD, FACP, AGSF, CMD, director of the Division of Geriatrics at Hackensack University Medical Center and co-director of the Center for Memory Loss and Brain Health at Hackensack University Medical Center, told Medical News Today that this discovery is significant because it offers a new way of looking at Alzheimer's.'For years, the fight against Alzheimer's has been dominated by a single-target approach, focusing almost exclusively on clearing amyloid plaques,' Parulekar, who was not involved in this study, explained.'But as dementia specialists, we know this is a multifaceted disease that affects the entire ecosystem of the brain. This study suggests a depletion of a natural element, and how restoring that balance could potentially impact all the major hallmarks of the disease — the plaques, the tangles, and cognitive function itself,' she said that these findings could potentially lead to new ways to both treat and detect Alzheimer's disease, but in very different ways.'Think of it like starting a healthy diet and exercise plan. If you start early, it can prevent heart disease. But even if you've already had a heart attack, starting that same healthy plan can still help you. It won't undo the past damage, but it will make your body stronger and help slow down future problems. Similarly, lithium seems to make the brain healthier and more resilient. So, it could be used as a treatment to protect the brain cells that are still healthy and slow down the progression of the disease in people who already have it.' – Manisha Parulekar, MD, FACP, AGSF, CMDPromising discovery for Alzheimer's detection and treatmentMNT also spoke to Peter Gliebus, MD, a neurologist, and director of cognitive and behavioral neurology at Marcus Neuroscience Institute, a part of Baptist Health South Florida, about this who was not involved in the recent study, said his first reaction to its findings is one of cautious optimism.'The study's findings indicate that lithium exhibits a substantial impact on brain health and may mitigate the early molecular alterations associated with Alzheimer's disease,' he said.'The study underscores the potential of lithium replacement therapy as a preventive or therapeutic intervention. This discovery holds a promise as it presents novel avenues for addressing the disease at its earliest stages, potentially slowing or even halting its progression,' Gliebus explained.'These findings have the potential to contribute to the early detection and treatment of Alzheimer's disease in the future,' he continued. The study shows lithium deficiency as an early indicator of Alzheimer's disease pathogenesis, potentially serving as a biomarker for early detection. Measuring lithium levels in the brain could enable the identification of individuals at higher risk of developing the disease.''Moreover, the therapeutic application of lithium orotate, which circumvents plaque sequestration, demonstrates promise in reversing or preventing pathological alterations in animal models,' Gliebus added. 'If these findings are validated in human studies, lithium replacement therapy could emerge as a viable treatment option, particularly for individuals experiencing early cognitive decline or at elevated risk for Alzheimer's disease.'


The Independent
12 hours ago
- The Independent
Rising sea levels could erase one of the planet's iconic heritage sites
A new study warns that rising sea levels could threaten Easter Island 's iconic moai statues and other cultural sites by the end of this century. The research, published in the Journal of Cultural Heritage, specifically highlights that the 15 monumental figures at Ahu Tongariki could be inundated by powerful seasonal waves. Lead author Noah Paoa and his team used a high-resolution "digital twin" of the island's coastline to model future wave impacts, predicting waves could reach Ahu Tongariki as early as 2080. The site at Ahu Tongariki, a UNESCO World Heritage site, is vital for the island's tourism economy and cultural identity, attracting tens of thousands of visitors annually. The study urges proactive measures such as coastal armoring, breakwaters, or even relocating the monuments to prevent irreversible damage to these globally significant heritage sites.


The Independent
13 hours ago
- The Independent
Rising seas could put Easter Island's moai at risk by 2080, study warns
By the end of the century, rising sea levels could push powerful seasonal waves into Easter Island's 15 iconic moai statues, according to a new study published in the Journal of Cultural Heritage. About 50 other cultural sites in the area are also at risk from flooding. 'Sea level rise is real,' said Noah Paoa, lead author of the study and a doctoral student at the University of Hawaii at Manoa's School of Ocean and Earth Science and Technology. 'It's not a distant threat.' Paoa, who is from Easter Island — known to its Indigenous people as Rapa Nui — and his colleagues built a high-resolution 'digital twin' of the island's eastern coastline and ran computer models to simulate future wave impacts under various sea level rise scenarios. They then overlaid the results with maps of cultural sites to pinpoint which places could be inundated in the coming decades. The findings show waves could reach Ahu Tongariki, the largest ceremonial platform on the island, as early as 2080. The site, home to the 15 towering moai, draws tens of thousands of visitors each year and is a cornerstone of the island's tourism economy. Beyond its economic value, the ahu is deeply woven into Rapa Nui's cultural identity. It lies within Rapa Nui National Park, which encompasses much of the island and is recognized as a UNESCO World Heritage site. The roughly 900 moai statues across the island were built by the Rapa Nui people between the 10th and 16th centuries to honor important ancestors and chiefs. The threat isn't unprecedented. In 1960, the largest earthquake ever recorded — a magnitude 9.5 off the coast of Chile — sent a tsunami surging across the Pacific. It struck Rapa Nui and swept the already-toppled moai further inland, which damaged some of their features. The monument was restored in the 1990s. While the study focuses on Rapa Nui, its conclusions echo a wider reality: cultural heritage sites worldwide are increasingly endangered by rising seas. A UNESCO report published last month found that about 50 World Heritage sites are highly exposed to coastal flooding. A UNESCO spokesperson said that relevant experts weren't immediately available for comment. Possible defenses for Ahu Tongariki range from armoring the coastline and building breakwaters to relocating the monuments. Paoa hopes that the findings will bring these conversations about now, rather than after irreversible damage. 'It's best to look ahead and be proactive instead of reactive to the potential threats,' he said. ___ Follow Annika Hammerschlag on Instagram: @ahammergram ___ The Associated Press receives support from the Walton Family Foundation for coverage of water and environmental policy. The AP is solely responsible for all content. For all of AP's environmental coverage, visit